Step-by-step IVUS and OCT guided PCI

Dr. Ozan Demir is a Structural and Interventional Cardiology Fellow at Hammersmith Hospital London. He recently completed post as Clinical Research Fellow at St Thomas’ Hospital and King’s College London, where he is undertook a PhD in coronary physiology under the supervision of Professor Divaka Perera. He studied Medicine at King’s College London and trained in London prior to undertaking Interventional Cardiology Fellowships at Hammersmith Hospital, London and San Raffaele, Milano. During his Fellowship in Milano, under the supervision of Professor Antonio Colombo and Professor Azeem Latib, he undertook an MSc in Interventional Cardiology at the Università Vita-Salute San Raffaele. He is currently involved in various clinical research studies on cardiovascular physiology.

Asst. Prof. Pawel Gasior is an interventional cardiology fellow in Division of Cardiology and Structural Heart Diseases, Medical University of Silesia in Poland. He is a Fellow of the European Society of Cardiology and the currently act as co-chair of the EAPCI New Initiatives for Young Interventionalists Committee. Following graduation from Medical University of Silesia he undertook research fellowship at Cardiovascular Research Foundation in New York under supervision of Dr. Juan Granada. Besides clinical medicine, he is also engaged in both clinical and preclinical research on intravascular imaging, new intravascular technologies, coronary physiology and coronary artery disease.

Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.